Equillium, Inc.
EQDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 13, 2026
5wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
How EQ's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
EQ101 | Phase 2 | Alopecia Areata | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Equillium, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Equillium, Inc.'s (EQ) pipeline across Phase 2. Its lead program is EQ101 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Equillium, Inc.'s next FDA catalyst?→
Equillium, Inc.'s (EQ) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track EQ biotech catalysts?→
Add EQ to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Equillium, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.